+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Management Systems (CTMS): Global Strategic Business Report

  • PDF Icon

    Report

  • 208 Pages
  • December 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1824112

Quick Summary:

Navigating the evolving landscape of the Clinical Trial Management Systems (CTMS) market requires knowledge that goes far beyond the baseline data. In the fast-paced healthcare technology sector, having critical insights gives you a strategic advantage. Investing in our comprehensive market research report propels you ahead of today's kinetic business environment, geared towards driving your business towards profitable growth.

Our global Clinical Trial Management Systems (CTMS) market report meticulously analyzes factors driving the market's projected rise to US$4 billion by 2030, inclusive of segment flags such as Enterprise-Wide CTMS and On-Site CTMS. Notably, the analysis delves into geographical variances, highlighting growth trajectories across key markets such as the US and China. This report also incorporates a comparative analysis of major competitors, offering valuable insights into their market shares and competitive strategies.


Our offering doesn't just provide data, but insight into what's shaping the industry, allowing for impactful decision-making, and providing a key tool for strategic planning. With access to our digital archives and the choice for complimentary updates for one year, you can trust us as your resource in commanding your competitive edge in the CTMS market.

Global Clinical Trial Management Systems (CTMS) Market to Reach $4 Billion by 2030

The global market for Clinical Trial Management Systems (CTMS) estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$4 Billion by 2030, growing at a CAGR of 14% over the analysis period 2022-2030. Enterprise-Wide CTMS, one of the segments analyzed in the report, is projected to record 14.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the On-Site CTMS segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $411.1 Million, While China is Forecast to Grow at 13.2% CAGR

The Clinical Trial Management Systems (CTMS) market in the U.S. is estimated at US$411.1 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$684.9 Million by the year 2030 trailing a CAGR of 13.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Select Competitors (Total 71 Featured) -

  • ArisGlobal LLC
  • BioClinica Inc.
  • Bio-Optronics Inc.
  • DSG Inc.
  • eResearch Technology Inc.
  • IBM Watson Health
  • Medidata Solutions
  • MedNet Solutions
  • Nextrials Inc.
  • Oracle Corp.
  • PAREXEL International Corp.
  • Trial By Fire Solutions LLC
  • Veeva Systems Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Clinical Trial Management Systems (CTMS)

What is the estimated value of the Global Market for Clinical Trial Management Systems (CTMS)?

The Global Market for Clinical Trial Management Systems (CTMS) was estimated to be valued at $1 Billion in 2020.

What is the growth rate of the Global Market for Clinical Trial Management Systems (CTMS)?

The growth rate of the Global Market for Clinical Trial Management Systems (CTMS) is 14.6%, with an estimated value of $2.6 Billion by 2027.

What is the forecasted size of the Global Market for Clinical Trial Management Systems (CTMS)?

The Global Market for Clinical Trial Management Systems (CTMS) is estimated to be worth $2.6 Billion by 2027.

Who are the key companies in the Global Market for Clinical Trial Management Systems (CTMS)?

Key companies in the Global Market for Clinical Trial Management Systems (CTMS) include ArisGlobal LLC, BioClinica Inc., Bio, Optronics Inc., DSG Inc., eResearch Technology Inc., IBM Watson Health, Medidata Solutions, MedNet Solutions and Nextrials Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Clinical Trial Management Systems (CTMS) Gain Ground
  • Recent Market Activity
  • Benefits Offered by CTMS
  • Global Market Overview
  • Clinical Trial Management Systems Market to Post Explosive Growth
  • Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
  • Key Players in the CTMS Market
  • Developed Countries Rule the Market
  • Pharmaceutical Firms and CROs to Drive Adoption Rate
  • Noteworthy Transformations in the Global Clinical Trial Sector
  • Clinical Trial Management Systems (CTMS) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Clinical Trial Globalization Surges Demand for CTMS
2. FOCUS ON SELECT PLAYERS
  • ArisGlobal, LLC (USA)
  • BioClinica, Inc. (USA)
  • Bio-Optronics, Inc. (USA)
  • DSG, Inc. (USA)
  • eResearch Technology, Inc. (USA)
  • IBM Watson Health (USA)
  • MedNet Solutions (USA)
  • Medidata Solutions (USA)
  • Nextrials, Inc. (USA)
  • Oracle Corp. (USA)
  • PAREXEL International Corp. (USA)
  • Trial By Fire Solutions, LLC (USA)
  • Veeva Systems, Inc. (USA)
  • Winchester Business Systems (USA)
3. MARKET TRENDS & DRIVERS
  • Surging Global Population Offers Increased Growth Opportunities
  • Increased Spend on R&D - An Important Growth Driver
  • CROs - The Targeted Customers for CTMS
  • Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand
  • CROs Adept with New Technologies to See More Business in Future
  • Rise in Clinical Trial Complexities Propels CTMS Demand
  • Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand
  • Adoption of Digital Technologies Gains Pace
  • Clinical Trial Operators Demand Efficient Data Management Platforms
  • DLB System’s Solution with Data Management Tools
  • Systems Integration Becomes Imperative
  • Technological Innovations Drive Market Growth
  • MC10 Introduces BioStampRC System to Capture Clinical Trial Data
  • UF Health Cancer Center Unveils OnCore® Clinical Trials Management System
  • UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Licensed Enterprise (On-Premise) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Enterprise-Wide CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for On-Site CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Web-Based (On-demand) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Cloud (SaaS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Large Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 27: World 16-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 29: World Historic Review for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 30: World 16-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 32: World Historic Review for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 33: World 16-Year Perspective for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 34: World Clinical Trial Management Systems (CTMS) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ArisGlobal LLC
  • BioClinica Inc.
  • Bio-Optronics Inc.
  • DSG Inc.
  • eResearch Technology Inc.
  • IBM Watson Health
  • Medidata Solutions
  • MedNet Solutions
  • Nextrials Inc.
  • Oracle Corp.
  • PAREXEL International Corp.
  • Trial By Fire Solutions LLC
  • Veeva Systems Inc.